ACADIA Pharmaceuticals, Inc. (ACAD)
22.17
+0.92
(+4.33%)
USD |
NASDAQ |
Apr 17, 16:00
22.16
-0.01
(-0.05%)
After-Hours: 20:00
ACADIA Pharmaceuticals SG&A Expense (Quarterly) : 155.62M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insmed, Inc. | 212.48M |
| Madrigal Pharmaceuticals, Inc. | 239.98M |
| Merck & Co., Inc. | 2.898B |
| Axsome Therapeutics, Inc. | 169.30M |
| Marker Therapeutics, Inc. | 0.8466M |